Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation.
about
The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cellsIntracellular Transport Routes for MHC I and Their Relevance for Antigen Cross-PresentationDirect presentation is sufficient for an efficient anti-viral CD8+ T cell response.Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection.Male accessory gland infection and sperm parameters (review).Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaquesDeletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigensStrategies for designing and optimizing new generation vaccines.In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responsesProtection and compensation in the influenza virus-specific CD8+ T cell responseSome interfaces of dendritic cell biology.Mice completely lacking immunoproteasomes show major changes in antigen presentationThe role of insulin-regulated aminopeptidase in MHC class I antigen presentation.Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis.Cross-presentation: underlying mechanisms and role in immune surveillance.Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens.Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patientsCharacterization of CD8+ T cell function and immunodominance generated with an H2O2-inactivated whole-virus vaccine.The cross-priming pathway: a portrait of an intricate immune system.T-cell immunity generated by recombinant adenovirus vaccines.A CD74-dependent MHC class I endolysosomal cross-presentation pathway.The cell biology of cross-presentation and the role of dendritic cell subsets.Geography and plumbing control the T cell response to infection.The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation.Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines.The outcome of cross-priming during virus infection is not directly linked to the ability of the antigen to be cross-presented.Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates.Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens.Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells.
P2860
Q24310853-3F4C73B6-AB3D-4A77-9F29-69CC54E2CD57Q26801963-C2060C9A-2126-4665-81A0-C4D8B60576D8Q33532640-571929E4-062D-4060-BD9A-4FC6561A30C5Q33780559-D6263575-5CA6-45FF-A9EA-C2FB84AF6814Q33947075-7EFFDAE5-1C86-4AC4-98BA-D210A14BE7C6Q34194671-AA738DBE-7E06-47E7-A205-D1F172932ED6Q34462167-DB4548BC-3267-4B6B-85F0-40D4577DDE61Q34465228-95775E8E-1332-4C34-802F-4BD47A7BA97BQ34572198-8A03F189-A868-4219-AFB0-F557F33F5AB7Q35019317-7925DE9B-CE93-4FD6-9809-164CD08C69F8Q35163418-058963FB-93B4-42A2-A43C-3A3A6C586E91Q35219290-AD16D478-C6AD-40E7-B5AF-555AD53A1E1EQ35685470-5FEAC783-C4A2-4EA8-9BB7-952591D22C52Q35928365-C2130678-DCFC-4A65-89D2-614E5DCF14C3Q35947214-8AB73406-0F65-4717-BF5A-7E2AEF22384AQ36266474-EDBA8103-097C-465C-BD05-927451D6EC5AQ36313784-D79C55FE-76EB-4C04-88DE-8AB8C1102C67Q36315031-8140B800-8E4A-4FCA-8095-6A65E8D2E8DEQ36370281-55AD35BC-1FE5-4407-ABC1-526BFFA6C5D9Q36376041-D2CBBFBC-D727-437C-9AEE-97FAC6CFF5E5Q36399737-4198E3CB-431C-463A-B1D4-D6EAF18DF213Q36414246-54F7F927-C00D-495A-AA9D-E4CCCDF58877Q36770431-F83845A2-3619-4034-A57D-54B81EEBE118Q36837129-035A334D-D16D-4BD6-B87E-391FEBAFAB21Q37066760-DD4D8022-7AE3-4B99-B474-A8D919D50DAFQ37082455-F224FAFE-193F-4AA6-A147-78E349630260Q37129841-07B3637E-9571-4A1B-818C-4C8FA4A107A1Q37372907-AB57E79D-C311-479F-8EBC-AB965D2707F4Q38620773-25C15514-8AE0-4CF1-8B94-72EBE663ABDDQ39697546-CE2CFAF8-8430-4A5A-9D26-2F81D181E107Q40432390-45305EB8-AABA-420C-A6D8-1C5517739857Q40700979-CD8C5AE3-21BE-41CF-9C17-34A0053D3952Q40724742-6401D1B5-5896-4354-A891-D587774853EEQ40726357-0920FF99-65E1-4506-BD6E-463123B8F79FQ40761219-CACA5210-AB28-44B7-AD8E-58868778BE2BQ50849295-24058100-3C3D-47C6-9961-463DBAFBD2B4
P2860
Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Bone marrow-derived antigen-pr ...... hways of antigen presentation.
@ast
Bone marrow-derived antigen-pr ...... hways of antigen presentation.
@en
type
label
Bone marrow-derived antigen-pr ...... hways of antigen presentation.
@ast
Bone marrow-derived antigen-pr ...... hways of antigen presentation.
@en
prefLabel
Bone marrow-derived antigen-pr ...... hways of antigen presentation.
@ast
Bone marrow-derived antigen-pr ...... hways of antigen presentation.
@en
P2860
P921
P356
P1476
Bone marrow-derived antigen-pr ...... hways of antigen presentation.
@en
P2093
P2860
P304
P356
10.1084/JEM.192.8.1143
P407
P577
2000-10-01T00:00:00Z